StockData
Perspective Therapeutics, Inc. logo

Perspective Therapeutics, Inc. (CATX) stock

CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)

Close on Nov 20, 2026Market cap $86.05MP/E –Yield –

Perspective Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Perspective Therapeutics's operating margin for the twelve months ending Jun 30, 2022 was -59.5%. For fiscal 2022 it was -59.5%, against -34.3% the year before. The highest annual figure on record is -34.3% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2022Jun 30, 2022-59.5%−25.2
FY2021Jun 30, 2021-34.3%+1.6
FY2020Jun 30, 2020-35.9%+35.9
FY2019Jun 30, 2019-71.8%+41.8
FY2018Jun 30, 2018-113.6%+18.9
FY2017Jun 30, 2017-132.5%−25.9
FY2016Jun 30, 2016-106.6%−12.4
FY2015Jun 30, 2015-94.2%+14.6
FY2014Jun 30, 2014-108.7%−18.9
FY2013Jun 30, 2013-89.9%−18.9
FY2012Jun 30, 2012-71.0%−14.4
FY2011Jun 30, 2011-56.6%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2022CQ2 2022Jun 30, 2022-84.1%−43.7
Q3 FY2022CQ1 2022Mar 31, 2022-47.3%−17.8
Q2 FY2022CQ4 2021Dec 31, 2021-58.1%−21.1
Q1 FY2022CQ3 2021Sep 30, 2021-88.7%−58.7
Q4 FY2021CQ2 2021Jun 30, 2021-40.3%+11.8
Q3 FY2021CQ1 2021Mar 31, 2021-29.5%−10.4
Q2 FY2021CQ4 2020Dec 31, 2020-37.0%+3.9
Q1 FY2021CQ3 2020Sep 30, 2020-29.9%+6.2
Q4 FY2020CQ2 2020Jun 30, 2020-52.2%+7.3
Q3 FY2020CQ1 2020Mar 31, 2020-19.0%+41.4
Q2 FY2020CQ4 2019Dec 31, 2019-40.9%+34.1
Q1 FY2020CQ3 2019Sep 30, 2019-36.1%+61.1
Q4 FY2019CQ2 2019Jun 30, 2019-59.5%+88.4
Q3 FY2019CQ1 2019Mar 31, 2019-60.4%+24.7
Q2 FY2019CQ4 2018Dec 31, 2018-75.1%+20.5
Q1 FY2019CQ3 2018Sep 30, 2018-97.2%+31.0
Q4 FY2018CQ2 2018Jun 30, 2018-147.8%−11.8
Q3 FY2018CQ1 2018Mar 31, 2018-85.1%+23.2
Q2 FY2018CQ4 2017Dec 31, 2017-95.6%+48.3
Q1 FY2018CQ3 2017Sep 30, 2017-128.2%+17.5
Q4 FY2017CQ2 2017Jun 30, 2017-136.1%−24.1
Q3 FY2017CQ1 2017Mar 31, 2017-108.3%+2.4
Q2 FY2017CQ4 2016Dec 31, 2016-143.9%−25.3
Q1 FY2017CQ3 2016Sep 30, 2016-145.7%−59.2
Q4 FY2016CQ2 2016Jun 30, 2016-112.0%−29.6
Q3 FY2016CQ1 2016Mar 31, 2016-110.8%−20.0
Q2 FY2016CQ4 2015Dec 31, 2015-118.6%–
Q1 FY2016CQ3 2015Sep 30, 2015-86.5%–
Q4 FY2015CQ2 2015Jun 30, 2015-82.4%–
Q3 FY2015CQ1 2015Mar 31, 2015-90.8%–

More Perspective Therapeutics figures

See a number that looks wrong?